XETR
M12
Market cap319mUSD
Jun 10, Last price
15.04EUR
1D
-3.09%
1Q
5.54%
Jan 2017
42.63%
IPO
189.23%
Name
M1 Kliniken AG
Chart & Performance
Profile
M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic and plastic surgery in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. The company operates in two segments, Beauty and Trade. It develops and markets pharmaceutical, medical, and medical technology products for aesthetic medicine and cosmetic dermatology, as well as trades in pharmaceutical, biosimilars, and other medical products and devices in the areas of oncology, HIV, rheumatism, neurology, cardiovascular diseases, and narcotics. The company also engages in the acquisition, management, and sale of real estate, primarily in the health care sector. It offers its products to doctors, pharmacies, and wholesalers under the M1 Select brand. The company operates a network of outpatient specialist centers; and a specialized surgical clinic center, as well as 46 specialist centers under the M1 Med Beauty brand. M1 Kliniken AG was founded in 2007 and is based in Berlin, Germany. M1 Kliniken AG operates as a subsidiary of MPH Health Care AG.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 316,319 10.88% | 285,291 -9.32% | |||||||
Cost of revenue | 290,894 | 272,554 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 25,424 | 12,737 | |||||||
NOPBT Margin | 8.04% | 4.46% | |||||||
Operating Taxes | 4,779 | 3,163 | |||||||
Tax Rate | 18.80% | 24.83% | |||||||
NOPAT | 20,645 | 9,574 | |||||||
Net income | 10,274 137.98% | 4,317 -51.52% | |||||||
Dividends | (1,981) | (1,823) | |||||||
Dividend yield | 0.92% | 1.10% | |||||||
Proceeds from repurchase of equity | 3,949 | 13,804 | |||||||
BB yield | -1.84% | -8.32% | |||||||
Debt | |||||||||
Debt current | 2,971 | 6,219 | |||||||
Long-term debt | 20,493 | 13,449 | |||||||
Deferred revenue | 10,324 | ||||||||
Other long-term liabilities | 11 | 54 | |||||||
Net debt | (231) | (39,834) | |||||||
Cash flow | |||||||||
Cash from operating activities | 8,917 | 21,023 | |||||||
CAPEX | (455) | (1,772) | |||||||
Cash from investing activities | (9,364) | (1,770) | |||||||
Cash from financing activities | (14,809) | (21,968) | |||||||
FCF | 14,149 | 15,192 | |||||||
Balance | |||||||||
Cash | 22,756 | 47,499 | |||||||
Long term investments | 939 | 12,003 | |||||||
Excess cash | 7,879 | 45,237 | |||||||
Stockholders' equity | 99,734 | 107,095 | |||||||
Invested Capital | 148,025 | 114,863 | |||||||
ROIC | 15.71% | 8.03% | |||||||
ROCE | 16.12% | 7.81% | |||||||
EV | |||||||||
Common stock shares outstanding | 19,126 | 18,315 | |||||||
Price | 11.20 23.62% | 9.06 20.80% | |||||||
Market cap | 214,210 29.09% | 165,934 19.08% | |||||||
EV | 243,953 | 175,532 | |||||||
EBITDA | 30,735 | 18,600 | |||||||
EV/EBITDA | 7.94 | 9.44 | |||||||
Interest | 1,347 | 828 | |||||||
Interest/NOPBT | 5.30% | 6.50% |